Literature DB >> 25228672

Computerized clinical decision support improves warfarin management and decreases recurrent venous thromboembolism.

Scott C Woller1, Scott M Stevens2, Steven Towner3, Jeff Olson4, Paige Christensen3, Sharon Hamilton5, Laurel Newman5, Loren Mott5, Ping Hu6, Kimberly D Brunisholz5, Yenh Long7, Jim Lloyd8, R Scott Evans8, Wayne Cannon5, C Greg Elliott2.   

Abstract

BACKGROUND: An explicit approach to warfarin dose adjustment using computerized clinical decision support (CDS) improves warfarin management. We report metrics of quality for warfarin management before and after implementation of CDS in a large health care system.
METHODS: A total of 2591 chronically anticoagulated patients were eligible for inclusion. We compared interpatient time in therapeutic range (TTR) and international normalized ratio (INR) variability before and after implementation of CDS. We report outcomes of major bleeding, thrombosis, and health care utilization.
RESULTS: Implementation of CDS significantly improved TTR (from 63.99% to 65.13%; P = .04) and reduced out-of-range INRs (from 42.39% to 39.97%; P < .001). Venous thromboembolism (relative risk [RR] 0.41; P < .001) emergency department utilization (RR 0.62; P < .001), and hospitalization (RR 0.62; P < .001) were reduced after CDS implementation. Major hemorrhage was more frequent after CDS implementation (RR 1.42; P = .01).
CONCLUSION: The CDS warfarin management was associated with improved TTR and decreased INR variability in a large cohort of chronically anticoagulated patients. Clinically relevant outcomes were broadly improved, although more bleeding events were observed.
© The Author(s) 2014.

Entities:  

Keywords:  anticoagulants; bleeding; clinical pharmacology; thrombosis

Mesh:

Substances:

Year:  2014        PMID: 25228672     DOI: 10.1177/1076029614550818

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  6 in total

1.  Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage.

Authors:  Daniel Fischer; Jeffrey Sorensen; Gabriel V Fontaine
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

2.  Resuming anticoagulation after brain hemorrhage while on warfarin treatment: INR at the time of bleeding should be taken into consideration.

Authors:  Maurizio Balestrino; Chiara Bruno; Cinzia Finocchi; Carlo Gandolfo
Journal:  Intern Emerg Med       Date:  2015-02-25       Impact factor: 3.397

3.  The Use of Evidence-Based, Problem-Oriented Templates as a Clinical Decision Support in an Inpatient Electronic Health Record System.

Authors:  Raj Mehta; Nila S Radhakrishnan; Carrie D Warring; Ankur Jain; Jorge Fuentes; Angela Dolganiuc; Laura S Lourdes; John Busigin; Robert R Leverence
Journal:  Appl Clin Inform       Date:  2016-08-17       Impact factor: 2.342

4.  Patient compliance with an anticoagulation management system based on a smartphone application.

Authors:  Yetao Li; Li Dong; Daokang Xiang; Yongchun Zhang; Xinbu Chen; Juan Long; Xiulun Liu; Hailin Li; Yile Yi; Yongfeng Fan; Qihua Gong; Min Luo
Journal:  J Thromb Thrombolysis       Date:  2019-08       Impact factor: 2.300

5.  Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study.

Authors:  T Jared Bunch; Victoria Jacobs; Heidi May; Scott M Stevens; Brian Crandall; Michael Cutler; John D Day; Charles Mallender; Jeff Olson; Jeffrey Osborn; J Peter Weiss; Scott C Woller
Journal:  Clin Cardiol       Date:  2019-04-10       Impact factor: 2.882

6.  Electronic alerts, comparative practitioner metrics, and education improve thromboprophylaxis and reduce venous thrombosis in community hospitals.

Authors:  Scott C Woller; Scott M Stevens; R Scott Evans; Daniel Wray; John Christensen; Valerie T Aston; Matthew Wayne; James F Lloyd; Emily L Wilson; C Gregory Elliott
Journal:  Res Pract Thromb Haemost       Date:  2018-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.